InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: agamemnus post# 373

Thursday, 08/24/2017 9:46:32 AM

Thursday, August 24, 2017 9:46:32 AM

Post# of 449
I thought you may have also posted on Seeking Alpha.

I tend to agree with you but it is bizarre that the best Pharma did not make an offer just based on the fact that the stock trades at cash. Even a $10.00 offer would have only cost them 500mil.

The patents need to be worth something, the cash is cash and Asia has to have some value. Plus this is a potentially life saving drug and new rules are in place. This could be a blockbuster and even if approved with or without a label it is suicide to market this without big Pharma as a partner at the very least.

My wife works at PFE and does trials and even a quick look she saw liver toxicity issues and gave it a 50 50 chance.

Very surprising that the best they could do was a reverse merge with a private company. 2 CEO's gone this year. The street doesn't think much of this management.

Of course, that can change on a dime with approvals.